5HT1A AGONIST ACTIVITY AND THE ANTIDEPRESSANT EFFICACY OF LU AA21004

被引：0
|
作者：
Mayze, T. [1 ]
机构：
[1] Brisbane Clin, Brisbane, Qld, Australia
来源：
EUROPEAN PSYCHIATRY | 2010年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The novel antidepressant Lu AA21004 exerts its multi-modal activity through serotonergic targets
    Sanchez, C.
    Nielsen, S. M.
    Pehrson, A.
    Zhong, H.
    Lassen, A. B.
    Bisulco, S.
    Mork, A.
    Wegener, G.
    Stensbol, T. B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S404 - S405
  • [22] In vitro and in vivo effects of the multimodal antidepressant vortioxetine (Lu AA21004) at human and rat targets
    Westrich, Ligia
    Pehrson, Alan
    Zhong, Huailing
    Nielsen, Soren Moller
    Frederiksen, Kristen
    Stensbol, Tine Bryan
    Boyle, Noel
    Hentzer, Morten
    Sanchez, Connie
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2012, 16 : 47 - 47
  • [23] Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice
    Guilloux, Jean-Philippe
    Mendez-David, Indira
    Pehrson, Alan
    Guiard, Bruno P.
    Reperant, Christelle
    Orvoen, Sophie
    Gardier, Alain M.
    Hen, Rene
    Ebert, Bjarke
    Miller, Silke
    Sanchez, Connie
    David, Denis J.
    NEUROPHARMACOLOGY, 2013, 73 : 147 - 159
  • [24] Lu AA21004: a novel potential treatment for mood disorders
    Moore, N.
    Bang-Andersen, B.
    Brennum, L.
    Fredriksen, K.
    Hogg, S.
    Mork, A.
    Stensbol, T.
    Zhong, H.
    Sanchez, C.
    Smith, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S321 - S321
  • [25] EFFECT OF FOOD ON THE PHARMACOKINETICS OF LU AA21004 IN HEALTHY VOLUNTEERS
    Wang, Y.
    Wojtkowski, T.
    Agyemang, A.
    Homery, M-C
    Karim, A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1115 - 1115
  • [26] THE ABSOLUTE BIOAVAILABILITY AND CLINICAL PHARMACOKINETICS AFTER INTRAVENOUS AND ORAL ADMINISTRATION OF THE NOVEL ANTIDEPRESSANT LU AA21004
    Hojer, A. -M
    Areberg, J.
    Sogaard, B.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 150 - 150
  • [27] Memory deficits produced by serotonin depletion in rats are reversed by the multimodal antidepressant Lu AA21004, but not escitalopram
    Pehrson, A.
    du Jardin, K. Gaarn
    Jensen, J. Borno
    Sanchez, C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 193 - 193
  • [28] Effects of the multimodal antidepressant Lu AA21004 on rat synaptic and cellular hippocampal plasticity and memory recognition
    Haddjeri, N.
    Etievant, A.
    Pehrson, A.
    Sanchez, C.
    Betry, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S303 - S303
  • [29] Vortioxetine ( Lu AA21004), a multimodal antidepressant: differentiation from current antidepressants in animal models of depression
    Mork, A.
    Pehrson, A. L.
    Betry, C.
    David, D.
    Li, Y.
    Gulinello, M.
    Leiser, S. C.
    Haddjeri, N.
    Sanchez, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S392 - S393
  • [30] 5-HTT and 5-HT1A receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects
    Stenkrona, Per
    Halldin, Christer
    Lundberg, Johan
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (10) : 1190 - 1198
12345